Hidetoshi Eguchi
Papers
7
Total Citations
34
H-Index
3
About
Hidetoshi Eguchi is a leading surgical oncologist whose research focuses on advancing minimally invasive and neoadjuvant treatments for colorectal and gastric cancers. His major contributions span three key areas: optimizing total neoadjuvant therapy (TNT) combined with immunotherapy for locally advanced rectal cancer, developing predictive models for postoperative complications like low anterior resection syndrome (LARS), and pioneering the use of mixed reality 3D models during robotic surgery. Eguchi’s work on integrating nivolumab with TNT (11 citations) and his novel LARS prediction model (7 citations) have directly informed clinical decision-making, reducing unnecessary stoma creation and improving patient quality of life. He has also investigated biomarkers such as interleukin-6 and tumor necrosis factor-α for early detection of infectious complications, and identified risk factors for compartment syndrome in laparoscopic surgery. Notably, his case report on mixed reality–assisted robotic rectal surgery (6 citations) demonstrates his commitment to translating cutting-edge technology into the operating room. With a growing citation impact and a portfolio that bridges innovation and patient safety, Eguchi is shaping the future of precision surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7